PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
22739762-9	2012	With administration of norepinephrine there was a 2.2% (1.0-4.3%) decrease in skin oxygen saturation and scO2 decreased 6.2% (4.2-8.0%), with scapO2 remaining unaffected.	Norepinephrine	23-37	synthesis of cytochrome C oxidase 2	Homo sapiens	105-109	
34116546-8	2021	Our results showed the likelihood that dopamine, ephedrine, and norepinephrine had the lowest probability of decreasing ScO2.	Norepinephrine	64-78	synthesis of cytochrome C oxidase 2	Homo sapiens	120-124	
34116546-9	2021	The suggested rank order to maintain ScO2, from higher to lower, was dopamine <ephedrine <norepinephrine <phenylephrine.	Norepinephrine	90-104	synthesis of cytochrome C oxidase 2	Homo sapiens	37-41	
34116546-11	2021	Compared with dopamine, the mean difference (95% credible interval) of ScO2 reduction was: ephedrine -3.19 (-15.74, 8.82), norepinephrine -4.44 (-18.23, 9.63) and phenylephrine -6.93 (-18.31, 4.47).	Norepinephrine	123-137	synthesis of cytochrome C oxidase 2	Homo sapiens	71-75	
22739762-2	2012	Norepinephrine is routinely administered to maintain cerebral perfusion pressure and, thereby, cerebral blood flow, but norepinephrine reduces the scO2.	Norepinephrine	120-134	synthesis of cytochrome C oxidase 2	Homo sapiens	147-151	
22739762-3	2012	We hypothesized that norepinephrine-induced reduction in scO2 is influenced by cutaneous vasoconstriction.	Norepinephrine	21-35	synthesis of cytochrome C oxidase 2	Homo sapiens	57-61	
22739762-11	2012	However, a commonly used vasopressor norepinephrine disturbs skin oxygen saturation to an extent that influences scO2.	Norepinephrine	37-51	synthesis of cytochrome C oxidase 2	Homo sapiens	113-117